Terms: = Sarcomas AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Treatment
16 results:
1. miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment.
Wang T; Huang J; Chen G; Fu J; Li T; Zou X; Yi H
Int Immunopharmacol; 2024 Mar; 130():111702. PubMed ID: 38367464
[TBL] [Abstract] [Full Text] [Related]
2. Construction and validation of a novel NAD
Yu R; Lu G; Cheng B; Li J; Jiang Q; Lan X
J Orthop Res; 2024 May; 42(5):1086-1103. PubMed ID: 38047487
[TBL] [Abstract] [Full Text] [Related]
3. Nucleobindin-2 Mediates Transforming Growth Factor-β1-Driven Phenotypes in Zinc Finger E-Box Binding Homeobox 1-High Uterine Carcinosarcoma.
Kobayashi Y; Yokoi A; Hashimura M; Oguri Y; Konno R; Matsumoto T; Tochimoto M; Nakagawa M; Ishibashi Y; Ito T; Ohhigata K; Harada Y; Fukagawa N; Kodera Y; Saegusa M
Am J Pathol; 2023 Aug; 193(8):1116-1128. PubMed ID: 37169340
[TBL] [Abstract] [Full Text] [Related]
4. The mechanism of VCP-mediated metastasis of osteosarcoma based on cell autophagy and the EMT pathway.
Li AA; Zhang Y; Li F; Zhou Y; Liu ZL; Long XH
Clin Transl Oncol; 2023 Mar; 25(3):653-661. PubMed ID: 36284060
[TBL] [Abstract] [Full Text] [Related]
5. P144 a Transforming Growth Factor Beta Inhibitor Peptide, Generates Antifibrogenic Effects in a Radiotherapy Induced Fibrosis Model.
Cruz-Morande S; Dotor J; San-Julian M
Curr Oncol; 2022 Apr; 29(4):2650-2661. PubMed ID: 35448191
[TBL] [Abstract] [Full Text] [Related]
6. Platelet-Derived TGF-β Induces Tissue Factor Expression via the Smad3 Pathway in Osteosarcoma Cells.
Saito M; Ichikawa J; Ando T; Schoenecker JG; Ohba T; Koyama K; Suzuki-Inoue K; Haro H
J Bone Miner Res; 2018 Nov; 33(11):2048-2058. PubMed ID: 29949655
[TBL] [Abstract] [Full Text] [Related]
7. ING5 is a Potential Target for Osteosarcoma Therapy.
Zhang X; Xu ZH; Xie H; Sun YW; Liu J; Zhao YB
Technol Cancer Res Treat; 2018 Jan; 17():1533033818762680. PubMed ID: 29528777
[TBL] [Abstract] [Full Text] [Related]
8. Overexpression of miR-422a inhibits cell proliferation and invasion, and enhances chemosensitivity in osteosarcoma cells.
Liu M; Xiusheng H; Xiao X; Wang Y
Oncol Rep; 2016 Dec; 36(6):3371-3378. PubMed ID: 27779704
[TBL] [Abstract] [Full Text] [Related]
9. Role of TGF-β signaling in uterine carcinosarcoma.
Dwivedi SK; McMeekin SD; Slaughter K; Bhattacharya R
Oncotarget; 2015 Jun; 6(16):14646-55. PubMed ID: 25918253
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-β2.
Niu G; Li B; Sun L; An C
PLoS One; 2015; 10(3):e0119225. PubMed ID: 25793604
[TBL] [Abstract] [Full Text] [Related]
11. Prediction of signaling pathways involved in enterovirus 71 infection by algorithm analysis based on miRNA profiles and their target genes.
Bian L; Wang Y; Liu Q; Xia J; Long JE
Arch Virol; 2015 Jan; 160(1):173-82. PubMed ID: 25287131
[TBL] [Abstract] [Full Text] [Related]
12. Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.
Fotouhi O; Adel Fahmideh M; Kjellman M; Sulaiman L; Höög A; Zedenius J; Hashemi J; Larsson C
Epigenetics; 2014 Jul; 9(7):987-97. PubMed ID: 24762809
[TBL] [Abstract] [Full Text] [Related]
13. Peroxisome proliferator-activated receptor γ agonist efatutazone impairs transforming growth factor β2-induced motility of epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer cells.
Serizawa M; Murakami H; Watanabe M; Takahashi T; Yamamoto N; Koh Y
Cancer Sci; 2014 Jun; 105(6):683-9. PubMed ID: 24698130
[TBL] [Abstract] [Full Text] [Related]
14. Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets.
van Oosterwijk JG; Meijer D; van Ruler MA; van den Akker BE; Oosting J; Krenács T; Picci P; Flanagan AM; Liegl-Atzwanger B; Leithner A; Athanasou N; Daugaard S; Hogendoorn PC; Bovée JV
Am J Pathol; 2013 Apr; 182(4):1347-56. PubMed ID: 23415961
[TBL] [Abstract] [Full Text] [Related]
15. Syndecan-2 is a key regulator of transforming growth factor beta 2/smad2-mediated adhesion in fibrosarcoma cells.
Mytilinaiou M; Bano A; Nikitovic D; Berdiaki A; Voudouri K; Kalogeraki A; Karamanos NK; Tzanakakis GN
IUBMB Life; 2013 Feb; 65(2):134-43. PubMed ID: 23297089
[TBL] [Abstract] [Full Text] [Related]
16. Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD.
Wang H; Yang GH; Bu H; Zhou Q; Guo LX; Wang SL; Ye L
Int J Exp Pathol; 2003 Jun; 84(3):153-63. PubMed ID: 12974945
[TBL] [Abstract] [Full Text] [Related]
